美国伊利诺伊州芝加哥市 COVID-19 大流行期间慢性病成年人的焦虑和抑郁症状患病率及其对自我管理的影响：一项横断面调查。
Prevalence of anxiety and depressive symptoms and impact on self-management among adults with chronic conditions in Chicago, Illinois, USA, during the COVID-19 pandemic: a cross-sectional survey.
机构信息
Department of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Department of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
出版信息
BMJ Open. 2022 Jan 7;12(1):e052495. doi: 10.1136/bmjopen-2021-052495.
OBJECTIVES
To examine the prevalence of mental health symptoms during the first surge of COVID-19 in the USA, and their associations with COVID-19-related emotional distress, health self-management and healthcare utilisation.
DESIGN
Cross-sectional analysis of wave 3 (1-22 May 2020) survey data from the ongoing Chicago COVID-19 Comorbidities (C3) study.
SETTING
Seven academic and community health centres in Chicago, Illinois.
PARTICIPANTS
565 adults aged 23-88 with one or more chronic conditions completing at least one prior C3 study wave.
PRIMARY AND SECONDARY OUTCOME MEASURES
Clinically relevant anxiety and depressive symptoms as measured using Patient-Reported Outcomes Measurement Information System short forms. Self-reported emotional and health-related responses to COVID-19 were measured through a combination of single-item questions and validated measures.
RESULTS
Rates of anxiety and depressive symptoms were 14% (81/563) and 15% (84/563), respectively. Anxiety and depressive symptoms were then each separately associated with greater worry about contracting COVID-19 (relative risk (RR) 2.32, 95% CI 1.52 to 3.53; RR 1.67, 95% CI 1.10 to 2.54), greater stress (RR 4.93, 95% CI 3.20 to 7.59; RR 3.01, 95% CI 1.96 to 4.61) and loneliness (RR 3.82, 95% CI 2.21 to 6.60; RR 5.37, 95% CI 3.21 to 8.98), greater avoidance of the doctor (RR 1.62, 95% CI 1.06 to 2.49; RR 1.54, 95% CI 1.00 to 2.36) and difficulty managing health (least square means (LS Means) 6.09, 95% CI 5.25 to 6.92 vs 4.23, 95% CI 3.70 to 4.75; LS Means 5.85, 95% CI 5.04 to 6.65 vs 4.22, 95% CI 3.70 to 4.75) and medications (LS Means 3.71, 95% CI 2.98 to 4.43 vs 2.47, 95% CI 2.02 to 2.92) due to the pandemic.
CONCLUSIONS
Identifying and addressing mental health concerns may be an important factor to consider in COVID-19 prevention and management among high-risk medical populations.
目的
在美国 COVID-19 第一波疫情期间，调查心理健康症状的流行情况，并分析其与 COVID-19 相关情绪困扰、自我健康管理和医疗保健利用之间的关系。
设计
对正在进行的芝加哥 COVID-19 合并症（C3）研究中第 3 波（2020 年 5 月 1 日至 22 日）调查数据进行的横断面分析。
地点
伊利诺伊州芝加哥的 7 个学术和社区卫生中心。
参与者
565 名年龄在 23-88 岁之间、患有一种或多种慢性病并至少完成过一次 C3 研究波的成年人。
主要和次要结果测量
使用患者报告的结果测量信息系统短表评估有临床意义的焦虑和抑郁症状。通过单项问题和经过验证的措施的组合来衡量与 COVID-19 相关的情绪和健康反应。
结果
焦虑和抑郁症状的发生率分别为 14%（81/563）和 15%（84/563）。随后，焦虑和抑郁症状分别与对感染 COVID-19 的更大担忧（相对风险（RR）2.32，95%置信区间（CI）1.52 至 3.53；RR 1.67，95%CI 1.10 至 2.54）、更大的压力（RR 4.93，95%CI 3.20 至 7.59；RR 3.01，95%CI 1.96 至 4.61）和孤独感（RR 3.82，95%CI 2.21 至 6.60；RR 5.37，95%CI 3.21 至 8.98）、更不愿意看医生（RR 1.62，95%CI 1.06 至 2.49；RR 1.54，95%CI 1.00 至 2.36）和更难管理健康（最小二乘均值（LS 均值）6.09，95%CI 5.25 至 6.92 与 4.23，95%CI 3.70 至 4.75；LS 均值 5.85，95%CI 5.04 至 6.65 与 4.22，95%CI 3.70 至 4.75）和药物（LS 均值 3.71，95%CI 2.98 至 4.43 与 2.47，95%CI 2.02 至 2.92）有关。
结论
在高危医疗人群中，识别和处理心理健康问题可能是 COVID-19 预防和管理中需要考虑的一个重要因素。
Zotero 插件